ATE250228T1 - Verfahren zur diagnose von gefässerkrankungen und früher atheriosklerose - Google Patents

Verfahren zur diagnose von gefässerkrankungen und früher atheriosklerose

Info

Publication number
ATE250228T1
ATE250228T1 AT99933432T AT99933432T ATE250228T1 AT E250228 T1 ATE250228 T1 AT E250228T1 AT 99933432 T AT99933432 T AT 99933432T AT 99933432 T AT99933432 T AT 99933432T AT E250228 T1 ATE250228 T1 AT E250228T1
Authority
AT
Austria
Prior art keywords
early
atheriosclerosis
vascular diseases
diagnosing vascular
human
Prior art date
Application number
AT99933432T
Other languages
English (en)
Inventor
Johan Frostegard
Original Assignee
Athera Biotechnologies Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802402A external-priority patent/SE9802402D0/xx
Application filed by Athera Biotechnologies Ab filed Critical Athera Biotechnologies Ab
Application granted granted Critical
Publication of ATE250228T1 publication Critical patent/ATE250228T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99933432T 1998-07-03 1999-07-02 Verfahren zur diagnose von gefässerkrankungen und früher atheriosklerose ATE250228T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9802402A SE9802402D0 (sv) 1998-07-03 1998-07-03 Method of diagnosing cardiovascular disease and early atherosclerosis
US9174198P 1998-07-06 1998-07-06
PCT/SE1999/001208 WO2000002046A1 (en) 1998-07-03 1999-07-02 Method of diagnosing cardiovascular disease and early atherosclerosis

Publications (1)

Publication Number Publication Date
ATE250228T1 true ATE250228T1 (de) 2003-10-15

Family

ID=26663352

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933432T ATE250228T1 (de) 1998-07-03 1999-07-02 Verfahren zur diagnose von gefässerkrankungen und früher atheriosklerose

Country Status (7)

Country Link
EP (1) EP1095271B1 (de)
AT (1) ATE250228T1 (de)
AU (1) AU4948999A (de)
DE (1) DE69911417T2 (de)
DK (1) DK1095271T3 (de)
ES (1) ES2205853T3 (de)
WO (1) WO2000002046A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2000264646A1 (en) * 2000-08-11 2002-02-25 Timothy Gerard Dinan Diagnosing risk of development of cardiovascular disease
US20040241744A1 (en) * 2001-07-12 2004-12-02 Hiroaki Kohno Method of quantifying denatured lipoprotein, reagents for quantifying denatured lipoprotein, method of detecting circulatory disease and reagents for detecting circulatory disease
ATE463254T1 (de) 2004-04-15 2010-04-15 Athera Biotechnologies Ab Antikörper gegen phosphorylcholinkonjugate
MX2010004885A (es) * 2007-10-30 2010-08-04 Athera Biotechnologies Ab Diagnostico y metodos terapeuticos y composiciones para enfermedades cardiovasculares.
WO2012010290A1 (en) 2010-07-21 2012-01-26 Athera Biotechnologies Ab Diagnostic and therapeutic methods and compositions for metabolic disease
CN103906532B (zh) 2011-08-09 2018-01-26 阿瑟拉生物技术公司 结合磷酰胆碱（pc）和/或pc结合物的抗体
HUE045163T2 (hu) 2011-08-09 2019-12-30 Athera Biotechnologies Ab Új ellenanyagok foszforilkolin ellen
RU2506901C1 (ru) * 2012-08-03 2014-02-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СамГМУ Минздрава России) Способ прогнозирования развития сосудистых нарушений у больных гриппом
RU2506900C1 (ru) * 2012-08-03 2014-02-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования развития внутрисосудистых нарушений у больных гриппом
RU2544803C1 (ru) * 2013-11-06 2015-03-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования состояния тонуса сосудов мозга у больных гриппом

Also Published As

Publication number Publication date
DE69911417T2 (de) 2004-06-17
DK1095271T3 (da) 2003-12-15
AU4948999A (en) 2000-01-24
WO2000002046A1 (en) 2000-01-13
EP1095271A1 (de) 2001-05-02
ES2205853T3 (es) 2004-05-01
DE69911417D1 (de) 2003-10-23
EP1095271B1 (de) 2003-09-17

Similar Documents

Publication Publication Date Title
SE9802402D0 (sv) Method of diagnosing cardiovascular disease and early atherosclerosis
DE69603491D1 (de) Reagenz und verfahren zur differentiellen bestimmung von leukocyten im blut
DE69937368D1 (de) Nachweis von erkrankungen der nieren und behandlung
DE69638198D1 (de) Verfahren und Reagenz zur Behandlung von Krankheiten die von der Konzentration des Rezeptors für den Wachstumsfaktor der vaskulären Endothelzellen verursacht werden
ATE250228T1 (de) Verfahren zur diagnose von gefässerkrankungen und früher atheriosklerose
DE69130986D1 (de) Rotoren für die Analytik und Verfahren zur Analyse biologischer Fluide
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE227847T1 (de) Teststreifen zur visuellen ermittlung der blutglukose-konzentration
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
DE69837425D1 (de) Verfahren und Vorrichtung zur nichtinvasiven photoakustischen Messung von Blutglukose
ATE195149T1 (de) Protein-antagonisten der blut-koagulation und ihre verwendung
DE69621459D1 (de) Reagens und verfahren zur differentiellen bestimmung von leukozyten im blut
ES2103582T3 (es) Ensayo y kit.
DE3888998D1 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten.
DE69712079D1 (de) Diagnostisches verfahren für atherosklerosis
ATE217089T1 (de) Diagnostisches verfahren für atherosklerosis
DE59609198D1 (de) Verfahren und Reagenz zur spezifischen Bestimmung von LDL in Serumproben
AT367204B (de) Verfahren und reagenz zur bestimmung des haemoglobingehaltes des blutes
DE69625581D1 (de) Cyanidfreies Reagenz und Verfahren zur Bestimmung von Hämoglobin und Leukozytendifferenzierung
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
ATE284034T1 (de) Verfahren zum nachweis von protein s
ATE56990T1 (de) Verfahren und reagenz zur bestimmung von gesamt- bilirubin.
DE3889279D1 (de) Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B.
DE69016858D1 (de) Verfahren und Reagenziensatz zur Bestimmung der funktionalen Aktivität von Protein S in menschlichem Plasma.
ATE374370T1 (de) Verfahren zur diagnose von endometriose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1095271

Country of ref document: EP

REN Ceased due to non-payment of the annual fee